Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...

Just a few months after Medtronic resolved a late 2021 FDA warning letter describing quality control issues at the headquarters of its diabetes division, that segment of its business is in the hot ...

Moving its aggressive acquisition campaign into the field of diabetes management, Medtronic Inc., the world’s biggest medical device maker, agreed to buy Northridge-based MiniMed Inc. and an ...

GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the ...

Medtronic is expanding a recall of its MiniMed insulin pumps after a broken retainer ring led patients to receive the incorrect dose of insulin. The recall, first announced in November 2019, was ...

Please provide your email address to receive an email when new articles are posted on . Medtronic has recalled its 600 series of MiniMed insulin pumps due to a missing or broken retainer ring, which ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Medtronic has recalled some of its insulin ...